000			02206 a2200565 4500
005			20250517022116.0
264		0	_c20150930
008			201509s 0 0 eng d
022			_a1945-7197
024	7		_a10.1210/jc.2014-3023 _2doi
040			_aNLM _beng _cNLM
100	1		_aRuan, Maomei
245	0	0	_aIodide- and glucose-handling gene expression regulated by sorafenib or cabozantinib in papillary thyroid cancer. _h[electronic resource]
260			_bThe Journal of clinical endocrinology and metabolism _cMay 2015
300			_a1771-9 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnilides _xpharmacology
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aAutoantigens _xgenetics
650	0	4	_aCarcinoma, Papillary _xdrug therapy
650	0	4	_aCell Cycle _xdrug effects
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aGene Expression Regulation, Neoplastic _xdrug effects
650	0	4	_aGlucose Transporter Type 1 _xgenetics
650	0	4	_aGlucose Transporter Type 3 _xgenetics
650	0	4	_aHumans
650	0	4	_aIodide Peroxidase _xgenetics
650	0	4	_aIron-Binding Proteins _xgenetics
650	0	4	_aMicrofilament Proteins _xgenetics
650	0	4	_aMuscle Proteins _xgenetics
650	0	4	_aNiacinamide _xanalogs & derivatives
650	0	4	_aPhenylurea Compounds _xpharmacology
650	0	4	_aPhosphorylation _xdrug effects
650	0	4	_aProtein Kinase Inhibitors _xpharmacology
650	0	4	_aProto-Oncogene Proteins c-akt _xgenetics
650	0	4	_aProto-Oncogene Proteins c-ret _xgenetics
650	0	4	_aPyridines _xpharmacology
650	0	4	_aReceptors, Thyrotropin _xgenetics
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aSorafenib
650	0	4	_aSymporters _xgenetics
650	0	4	_aThyroid Neoplasms _xdrug therapy
700	1		_aLiu, Min
700	1		_aDong, Qianggang
700	1		_aChen, Libo
773	0		_tThe Journal of clinical endocrinology and metabolism _gvol. 100 _gno. 5 _gp. 1771-9
856	4	0	_uhttps://doi.org/10.1210/jc.2014-3023 _zAvailable from publisher's website
999			_c24705522 _d24705522